Search results
Surprise: Eli Lilly Is Racing Toward Yet Another Blockbuster
Motley Fool via Yahoo Finance· 3 hours agoEli Lilly just reported positive phase 3 results for this investigational therapy. Efsitora alfa was...
Healthy Returns: Eli Lilly, Novo Nordisk are competing to develop more convenient weekly insulins
NBC Washington· 2 days agoThe rivalry between Eli Lilly and Novo Nordisk extends beyond a buzzy class of weight loss and...
'Ozempic breasts' to 'Ozempic face': What you need to know about weight loss drug side effects
Euronews via Yahoo News· 4 days agoAdministered as a weekly injection, it functions by aiding the pancreas in insulin production. It...
Insulin pricing claims: deep dive for self-funded payers and advisors
BenefitsPRO· 2 hours agoThe insulin market is highly concentrated, with three manufacturers — Eli Lilly, Novo Nordisk, and Sanofi — dominating nearly 96% of ...
Eli Lilly says its experimental weekly insulin works just as well as daily doses
Quartz· 7 days agoPeople who depend on daily insulin shots may soon have welcome news: a new experimental drug could...
Eli Lilly's (LLY) Efsitora Matches Daily Insulins in A1C Control
Zacks via Yahoo Finance· 6 days agoEli Lilly's (LLY) two phase III studies on its once-weekly insulin, efsitora alfa, meet their...
Insulin would cost $35 max under proposed Ohio bill
Ohio Capital Journal via Yahoo News· 5 hours agoA bipartisan group of Ohio lawmakers has introduced a bill to cap the costs of the life-saving medication insulin to $35. Medication prices are rising,...
Eli Lilly: Weekly Insulin Dose On Par With Common Daily Doses - Eli Lilly and Co (NYSE:LLY)
Benzinga· 7 days agoEli Lilly and Co LLY released Thursday topline results from two phase 3 trials. The drugmaker...
Eli Lilly’s efsitora alfa shows promise in Phase III T2D trials
Clinical Trials Arena via Yahoo Finance· 6 days agoEli Lilly has reported positive outcomes from the Phase III QWINT-2 and QWINT-4 clinical trials of ...
It's Time for Over-the-Counter Ozempic
Reason.com via Yahoo News· 1 day agoIllustration: Lex Villena; Aniloracru The new insulin-stimulating weight-loss drugs semaglutide and tirzepatide appear impressive. Studies suggest they...
